RPM Plus Map Prescription Pills Image Visit the MSH Web Site  
Pattern
Rational Pharmaceutical Management Plus (RPM Plus)  
  Graduated Bar    
 
Search RPM Plus Site:


Senegal

Since 2001, RPM Plus has worked with the Ministry of Health (MoH) and other partners in Senegal to strengthen the pharmaceutical system in support of child health and malaria services.

In particular, RPM Plus has focused on the following areas—

Most recently, RPM Plus has also begun working with the MoH
to identify areas of strengthening to improve services for
HIV/AIDS and TB treatment and care.


Child Health and Malaria Activities

Working with the MoH and the Basic Support for the Institutionalizing Child Survival (BASICS) project, RPM Plus conducted a Drug Management for Childhood Illness (DMCI) assessment (report in both English [PDF - 310 KB] and French [PDF - 370 KB]) primarily in the public sector in 2001.

Then in 2002, a community-level drug management for childhood illnesses (C-DMCI) survey was also conducted (report in both English [PDF - 385 KB] and French [PDF - 425 KB]).


Highlights from the DMCI Assessment in Senegal

The Senegal DMCI survey was conducted on a national sample in September 2001. Some key findings include—
  • Some pharmaceuticals needed for IMCI were not on the essential medicines list and so were not procured.

  • Pharmaceuticals were procured at 90 percent of the International Median price (according to the 2000 MSH International Drug Price Indicator).

  • Stock-outs and poor availability of medicines (availability of a set of tracer medicines at peripheral facilities averaging 50 percent, and about 35 percent out of stock over a 12-month period) were in evidence, possibly due to inadequate distribution from district level stores to peripheral facilities.

  • An observed overuse of antibiotics for cases of diarrhea (64 percent) and non-pneumonia acute respiratory infection (69 percent) was associated with increased treatment costs.

  • The rate of use of oral rehydration salts (ORS) for diarrhea management was relatively low (60 percent) in public facilities, and ORS was not sold at all in simulated purchases conducted in the private sector.

  • On exiting the public facilities, caretakers of children often were not able to describe how to administer medication despite being given instructions by the provider (41 percent).

Highlights from the C-DMCI Assessment in Senegal


Senegalese boy

As a follow-on to the 2001 DMCI assessment, which focused primarily on the public sector health facilities, the MoH of Senegal, in collaboration with RPM Plus and the BASICS project, conducted an assessment using a newly developed Community Drug Management for Childhood Illness (C-DMCI) assessment tool.

Although the questionnaires had been field-tested, the sampling and survey methodology was being used for the first time. The survey took place between August and October 2002 in Kaolack and Thiès districts.

Some key findings include—


  • ORS, which is recommended as the first-line treatment for diarrhea by the Senegal IMCI guidelines, was not available in private pharmacies and was poorly available in the public sector.

  • Only 56 percent of the children with fever took the first-line antimalarial medicine, and fewer than 20 percent of children with pneumonia or diarrhea took the appropriate first-line treatment (co-trimoxazole and ORS, respectively).

  • In general, the medicines were not correctly administered in the home, even when instructions were given to caregivers at the time of purchase; only about 60 percent of patients took chloroquine for three days and fewer than 10 percent took chloroquine once a day for three days, as recommended.

  • Only around 30 percent of caregivers took children with symptoms of pneumonia for care on the same day symptoms started.

The results of both these surveys were discussed in strategy planning workshops in May 2002 (for the DMCI survey) and February 2003 (for the C-DMCI) with key stakeholders in country.

Action plans resulted and a selection of interventions was designed and is being implemented by the MoH in collaboration with other partners and with technical assistance from RPM Plus.

The interventions resulting from these planning sessions are—

  • Inventory Management
    In cooperation with BASICS and the MoH, RPM Plus worked to incorporate training in the principles of store management into IMCI training for head nurses at the health posts.

    A more simplified training module on store management was also developed for the training of storekeepers at health posts and health huts (case de santé).

    In collaboration with various sections of the MoH, RPM Plus facilitated a consultative meeting of a variety of stakeholders in 2003 to standardize and validate a set of stock management tools.

  • Private sector
    Responding to the finding of the surveys that ORS were not available in private pharmacies, a ministerial decree was issued allowing the sale of ORS and other key generic medicines to private wholesalers through the central medical stores (PNA).

    Additionally, RPM Plus has worked with the MoH and the association of private pharmacists to provide pharmacists working outside the public sector with additional training in rational use of medicines for childhood illnesses and general IMCI strategies, as outlined in the national treatment guidelines.

    Through meetings and discussions, private pharmacists also identified the need to inform their sales assistants of these strategies. In response, RPM Plus collaborated with the MoH Direction de pharmacie et laboratoire (DPL), and the Division d'alimentation et survie de l'enfant (DANSE), the syndicate, and BASICS to develop a training manual for sales assistants in private pharmacies on rational medicine use for childhood illness in the USAID intervention areas. Training has been completed in all USAID districts and a total of 685 out of 723 (or 95%) assistants were trained. Work is underway with the DPL and the syndicate of private pharmacists to develop the monitoring mechanism.

  • Community level
    Findings from the 2001 DMCI survey demonstrated that antibiotics, although not authorized at the health hut level, were widely available and not being used appropriately.

    As a result, operational research on the community case management of pneumonia [PDF - 62 KB] by the agents de santé communautaires (ASC) (community health workers) using co-trimoxazole was commissioned by the MoH. In support of this operations research conducted by a partnership of MoH, BASICS, and UNICEF, RPM Plus developed a training manual in store management, facilitated at the training sessions, and offered guidance on the supervision tools.

    » More on RPM Plus' work in Child Health



Malaria-specific activities

In 2003, Senegal changed its policy on first-line treatment for malaria from chloroquine to a combination therapy of amodiaquine and SP and plans for further treatment policy change to incorporate an amodiaquine/artesunate combination therapy for the treatment of malaria in 2006.

The early implementation of SP/AQ in a couple of pilot districts was studied by RPM Plus and the MoH malaria program to extract lessons to be learned for scale-up implementation (report in both English [PDF - 203 KB] and French [PDF - 234 KB]).

These lessons will be applied to the upcoming implementation of the new combination treatment planned for 2006.

In 2002, RPM Plus conducted formative research on intermittent preventive therapy (IPT) in pregnancy (report in both English [PDF - 500 KB] and French [PDF - 920 KB]) which showed that women did not receive antimalarials at prenatal clinics, but rather bought them from the private sector.

Through its regional malaria advisor, RPM Plus provides technical assistance to the malaria program and its partners assisting in issues such as quantification and planning of implementation of ACT introduction and IPT.

    » More on RPM Plus' work in Malaria

To the Top    

HIV/AIDS

Most recently, USAID/Senegal asked RPM Plus, in partnership with Family Health International (FHI) and MSH PREMOMA project, to complete an assessment of the pharmaceutical management and laboratory systems.

This assessment focused on the supply system of medicines and related supplies for antiretroviral therapy (ART), TB treatment, malaria treatment, and IPT for pregnant women.

Data collection was completed in April 2005 and the findings were disseminated at a workshop [PDF - 325 KB] in August 2005.

The survey (final report pending) evaluated, for pharmaceuticals as well as for laboratory reagents, issues of—

  • Policies, norms, legal framework, and human resources
  • Supply management
  • IPT implementation in prenatal consultations, financing, and health management information systems

Potential areas for interventions based on these recommendations were determined for each of the programs (malaria, TB, and HIV/AIDS) as well as for the central medical stores.

RPM Plus will work with the malaria and TB programs and with the central medical stores to improve the management and supply of commodities for these programs.

    » More on RPM Plus' work in TB

    » More on RPM Plus' work in HIV/AIDS

To the Top